Fenwick & West advised T-knife Therapeutics on the deal. Torys LLP acted as counsel to Sixty Degree Capital. T-knife Therapeutics, Inc., a next-generation T-cell receptor company...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here